Hosted on MSN1mon
MaxCyte: Building the Future of Cell and Gene Therapy InnovationCasgevy enables CRISPR/Cas-9 to edit the BCL11A gene in stem cells to produce fetal hemoglobin. The edited genes are infused into a patient's bone marrow to start producing red blood cells with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback